查看购物车
  • Traditional Chinese
  • English
月经症候群治疗市场规模、份额和成长分析（按产品类型、药物类型、分销管道和地区划分）－2026-2033年产业预测
市场调查报告书
商品编码
1913179

月经症候群治疗市场规模、份额和成长分析（按产品类型、药物类型、分销管道和地区划分）－2026-2033年产业预测

Premenstrual Syndrome Treatment Market Size, Share, and Growth Analysis, By Product (Prescription and Over-the-Counter (OTC)), By Drug Type (Analgesics, Antidepressants), By Distribution Channel, By Region-Industry Forecast 2026-2033.
出版日期: | 出版商: SkyQuest | 英文 189 Pages | 商品交期: 3-5个工作天内

价格
简介目录

全球月经症候群 (PMS) 治疗市场规模预计在 2024 年达到 19.5 亿美元，从 2025 年的 14.9 亿美元增长到 2033 年的 19.5 亿美元，在预测期（2026-2033 年）内复合年增长率为 3.42%。

全球月经症候群 (PMS) 治疗市场正经历成长，这主要得益于人们对 PMS 及其对女性健康影响的认识不断提高，以及对有效治疗方法的需求日益增长。与医疗保健领域向个人化、非侵入性治疗转变的大趋势相呼应，非荷尔蒙疗法疗法和综合疗法已显着增加。各大製药和医疗保健公司正积极投资研发，以推出创新治疗方法。然而，该市场也面临许多挑战，包括阻碍治疗方法核准和普及的监管壁垒，以及治疗通讯协定的不一致导致患者疗效的差异。随着 PMS 管理行动应用程式等数位健康解决方案的日益普及，资料隐私和安全问题变得至关重要。随着产业技术融合的发展，确保强而有力的资料保护将发挥关键作用。

全球月经综合症治疗市场按产品、药物、通路和地区进行细分。依产品划分，市场分为处方药和非处方药（OTC）。依药物划分，市场分为止痛药、抗忧郁剂、口服避孕药和卵巢抑制剂。按分销管道划分，市场分为药房/零售药房、医院药房和线上药房。按地区划分，市场分析涵盖北美、欧洲、亚太、拉丁美洲以及中东和非洲。

全球月经症候群治疗市场成长要素

人们对月经症候群 (PMS) 及其症状的认识不断提高，显着推动了市场对治疗方法的需求。宣传宣传活动和教育活动在提高女性对 PMS 的了解、并最终鼓励她们寻求医疗帮助方面发挥关键作用。诸如国际月经症候群协会 (IAPMD) 等致力于解决此问题的组织，正积极进行宣传活动，引导女性寻求医疗保健服务。 PMS 诊断率的提高导致对包括口服避孕药在内的各种治疗方法的需求增加，从而促进了全球月经治疗市场的扩张。

限制全球月经症候群治疗市场的因素

全球月经治疗市场面临许多挑战，其中包括由于社会对经前症候群相关心理健康问题的污名化，导致症状报告率偏低。在许多文化中，女性谈论经前症候群及其相关症状仍被视为禁忌，这使得她们不愿寻求治疗或公开谈论自身症状。这种文化上的抵触情绪降低了对有效治疗方法（如抗忧郁症和荷尔蒙疗法）的需求，从而阻碍了市场整体成长。因此，提高公众意识和促进社会接纳对于克服这些障碍、扩大患者的治疗选择至关重要。

全球月经症候群（PMS）治疗市场趋势

全球月经症候群 (PMS) 治疗市场正经历着向天然和整体疗法的显着转变，消费者越来越倾向于选择草药和植物来源治疗方法而非传统药物。这一趋势反映了人们健康意识的增强，以及对非药物替代疗法以缓解经前症候群症状（例如月经和情绪波动）的需求。添加维生素 B6、钙和镁等天然成分不仅吸引了寻求永续选择的消费者，也推动了创新草药疗法市场的成长。抓住这一需求的公司正在蓬勃发展，而对健康和福祉的重视正在改变经前症候群的管理方式。

目录

介绍

  • 调查目标
  • 调查范围
  • 定义

调查方法

  • 资讯收集
  • 二手资料和一手资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分市场机会分析

市场动态与展望

  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特分析

关键市场考察

  • 关键成功因素
  • 竞争程度
  • 关键投资机会
  • 市场生态系统
  • 市场吸引力指数（2025）
  • PESTEL 分析
  • 总体经济指标
  • 价值链分析
  • 定价分析
  • 案例研究
  • 顾客购买行为分析

全球月经症候群治疗市场规模（按产品和复合年增长率划分）（2026-2033 年）

  • 处方药
  • 非处方药

全球月经症候群治疗市场规模（按药物类型和复合年增长率划分）（2026-2033 年）

  • 止痛药
  • 抗忧郁症
  • 口服避孕药和卵巢抑制剂

全球月经症候群治疗市场规模（依分销管道划分）及复合年增长率（2026-2033 年）

  • 药局和零售药房
  • 医院药房
  • 网路药房

全球月经症候群治疗市场规模及复合年增长率（2026-2033）

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业的市场定位（2025 年）
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市占率分析（2025 年）
  • 主要企业公司简介
    • 公司详情
    • 产品系列分析
    • 依业务板块进行公司股票分析
    • 2023-2025年营收年比比较

主要企业简介

  • Bayer AG
  • Eli Lilly and Company
  • GlaxoSmithKline Plc
  • Pfizer Inc.
  • AbbVie Inc.
  • H. Lundbeck A/S
  • Dr. Reddy's Laboratories Ltd
  • BASF SE
  • SHIONOGI & Co. Ltd
  • Asarina Pharma AB
  • Teva Pharmaceutical Industries Ltd
  • Vistagen Therapeutics
  • Herbalife International of America, Inc.
  • The Nature's Bounty Co.
  • Johnson & Johnson Services

结论与建议

简介目录
Product Code: SQMIG35I2433

Global Premenstrual Syndrome Treatment Market size was valued at USD 1.44 Billion in 2024 and is poised to grow from USD 1.49 Billion in 2025 to USD 1.95 Billion by 2033, growing at a CAGR of 3.42% in the forecast period (2026-2033).

The global premenstrual syndrome (PMS) treatment market is experiencing growth driven by heightened awareness of PMS and its impact on women's health, alongside an increasing demand for effective treatment options. There is a significant shift toward non-hormonal and integrative therapies, mirroring broader healthcare trends toward personalized, non-invasive treatments. Major pharmaceutical and healthcare companies are actively investing in research and development to introduce innovative therapies. However, the market faces challenges, including regulatory hurdles that hinder treatment approval and accessibility, along with inconsistent treatment protocols leading to varied patient outcomes. As digital health solutions, like mobile apps for PMS management, gain traction, concerns regarding data privacy and security become paramount. Ensuring robust data protection will be critical as the industry evolves alongside technological integration.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Premenstrual Syndrome Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Premenstrual Syndrome Treatment Market Segments Analysis

The global premenstrual syndrome treatment market is segmented into product, drug, distribution channel, and region. by product, the market is classified into Prescription and Over-the-Counter (OTC). Depending on the drug, it is divided into Analgesics, Antidepressants, and Oral Contraceptives & Ovarian Suppression Agents. According to distribution channel, the market is categorized into Drug Stores & Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies. Regionally, it is analyzed across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Driver of the Global Premenstrual Syndrome Treatment Market

The growing awareness surrounding premenstrual syndrome (PMS) and its symptoms has significantly fueled the demand for treatment options in the market. Public awareness campaigns and educational initiatives play a crucial role in enhancing understanding among women regarding PMS, ultimately encouraging them to seek medical advice. Organizations dedicated to this cause, like the International Association for Premenstrual Disorders (IAPMD), actively promote awareness, leading women to healthcare providers. This increased diagnosis of PMS paves the way for a higher demand for various treatment options, including oral contraceptives, thus expanding the scope of the global premenstrual syndrome treatment market.

Restraints in the Global Premenstrual Syndrome Treatment Market

The Global Premenstrual Syndrome Treatment market faces significant challenges due to the stigma surrounding mental health issues associated with PMS, which often leads to underreporting of symptoms. In various cultures, discussing PMS and its related symptoms among women can be considered taboo, resulting in a reluctance to seek treatment or openly address the condition. This cultural reluctance diminishes the demand for effective therapies, such as antidepressants or hormonal treatments, thereby hindering the overall growth of the market. As a result, increased awareness and acceptance are necessary to help overcome these obstacles and expand treatment options for those affected.

Market Trends of the Global Premenstrual Syndrome Treatment Market

The Global Premenstrual Syndrome (PMS) Treatment market is witnessing a notable shift towards natural and holistic solutions, as consumers increasingly prefer herbal and plant-based remedies over traditional pharmaceuticals. This trend reflects a rising awareness of wellness and a desire for drug-free alternatives to alleviate PMS symptoms like cramping and mood swings. The incorporation of natural ingredients such as vitamin B6, calcium, and magnesium not only appeals to consumers seeking sustainable options but also fosters a growing market for innovative herbal treatments. Businesses tapping into this demand are thriving, contributing to a transformative landscape where health and wellness priorities shape PMS management.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Customer Buying Behavior Analysis

Global Premenstrual Syndrome Treatment Market Size by Product & CAGR (2026-2033)

  • Market Overview
  • Prescription
  • Over-the-Counter (OTC)

Global Premenstrual Syndrome Treatment Market Size by Drug Type & CAGR (2026-2033)

  • Market Overview
  • Analgesics
  • Antidepressants
  • Oral Contraceptives & Ovarian Suppression Agents

Global Premenstrual Syndrome Treatment Market Size by Distribution Channel & CAGR (2026-2033)

  • Market Overview
  • Drug Stores & Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

Global Premenstrual Syndrome Treatment Market Size & CAGR (2026-2033)

  • North America (Product, Drug Type, Distribution Channel)
    • US
    • Canada
  • Europe (Product, Drug Type, Distribution Channel)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, Drug Type, Distribution Channel)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, Drug Type, Distribution Channel)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Drug Type, Distribution Channel)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Bayer AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eli Lilly and Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GlaxoSmithKline Plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pfizer Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AbbVie Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • H. Lundbeck A/S
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dr. Reddy's Laboratories Ltd
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BASF SE
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SHIONOGI & Co. Ltd
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Asarina Pharma AB
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teva Pharmaceutical Industries Ltd
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vistagen Therapeutics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Herbalife International of America, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • The Nature's Bounty Co.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson Services
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations